VIVEbiotech Attends International Events in Rome and Seoul

VIVEbiotech continues to strengthen its global footprint in the cell and gene therapy space through its simultaneous participation in two major international advanced therapies events taking place in Europe and Asia at the end of April.

From April 28 to 30, the company will attend the Cell & Gene Meeting on the Med, held at the Rome Cavalieri Hotel in Rome, Italy, and BIO KOREA, hosted at the COEX convention center in Seoul, South Korea, where VIVEbiotech will participate as an exhibitor at booth L6. At both events, the team will showcase its lentiviral vector platform for in vivo and ex vivo applications, designed to support the development of next‑generation advanced therapies.

In Rome, VIVEbiotech will be represented by Patricio Massera, President and Board Member, and Jon Alberdi, CEO, who will engage with key stakeholders from the international cell and gene therapy community.

In Seoul, Natalia Elizalde, PhD, Chief Business Development Officer, and Víctor Martínez Polo, Business Development Manager, will lead the company’s presence at BIO KOREA, focusing on strategic partnership opportunities within the Asian biotech ecosystem.

Attendees interested in meeting with the VIVEbiotech team during either event can request a meeting through the official partnering platforms or contact the company directly via its corporate website.

• Cell & Gene Meeting on the Med: https://informaconnect.com/cell-gene-meeting-on-the-mediterranean/pone/login/
• BIO KOREA: https://www.biokorea.org/en/sso/form.do?key=2404190001

VIVEbiotech’s participation in these international advanced therapy events highlights its commitment to innovation, global collaboration, and strategic growth, reinforcing its position as a trusted partner in the development of cell and gene therapies worldwide.